Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin
-
Published:2018-09
Issue:
Volume:Volume 11
Page:335-345
-
ISSN:1178-7023
-
Container-title:Clinical and Experimental Gastroenterology
-
language:en
-
Short-container-title:CEG
Author:
Chang Christopher
Publisher
Informa UK Limited
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献